INTELLIA THERAPEUTICS INC
NTLANASDAQ🏆 #1803 by market capEarnings Nov 5US Equity
$799.72▲ $26.95 (+3.37%)
Simulated price1h—
24h▲ 3.4%
7d—
14d—
30d—
1y—
🏦Market Cap
$1.68B
Small Cap
📈Revenue Growth (YoY)
+12.6%
Healthy
📊Gross Margin
—
💵FCF Margin
94.8%
Strong
⚖️P/S Ratio
28.4x
Expensive
Otter Score
59
Weak
Earnings
Q3 · 2026Reported 2026-08-06Earnings Per Share
Actual
-0.80
Expected
-0.80
miss
−0.10%
YoY +19.20%
Revenue
Actual
$7.66M
Expected
$12.98M
miss
−41.00%
YoY −46.20%
Consensus estimates
Recent quarters
Q3 2026
-0.80
miss
Q2 2026
-0.81
beat
Q1 2026
-0.83
beat
Q4 2025
-0.92
beat